Serum interleukin-33 can be used as a biomarker for acute ischemic stroke prognosis

Takeaway

  • Lower serum interleukin-33 (IL-33) levels were associated with worse prognosis and recurrence of acute ischemic stroke (AIS).

Why this matters

    There is currently no biomarker that aids clinicians in evaluating and predicting outcomes associated with ischemic stroke.